TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: 8.70nMAssay Description:Antagonist activity at EP1 receptor (unknown origin) by reporter gene assayMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: 290nMAssay Description:Binding affinity to human EP1 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: 530nMAssay Description:Binding affinity to human EP1 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >2.70E+3nMAssay Description:Binding affinity to EP4 receptor (unknown origin)More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >2.70E+3nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >2.70E+3nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >2.70E+3nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >5.00E+3nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >5.00E+3nMAssay Description:Binding affinity to EP3 receptor (unknown origin)More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >5.00E+3nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >5.00E+3nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >8.00E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >8.00E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >8.00E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: 8.70E+3nMAssay Description:Binding affinity to human EP1 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataKi: >8.70E+3nMAssay Description:Binding affinity to EP2 receptor (unknown origin)More data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at EP1 receptor (unknown origin) by reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
In DepthDetails
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at EP1 receptor (unknown origin) by reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Antagonist activity at EP1 receptor (unknown origin) by reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In DepthDetails
![](/img/powered_by_small.gif)